More about
Progressive Myasthenia Gravis
CME
Video
Generalized Myasthenia Gravis: Understanding the Role of FcRn Antagonists
This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
News
August 14, 2024
1 min read
Save
FDA grants RMAT designation to myasthenia gravis therapeutic
The FDA has granted Regenerative Medicine Advanced Therapy designation to an autologous, fully human CD19 chimeric antigen receptor T-cell therapy candidate, to treat those with progressive myasthenia gravis.
CME
Video
Generalized Myasthenia Gravis: Unlocking New Treatment Options to Advance Patient Care
This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.